Martin Worley Group
- SEC CIK
- 0002049542
- Latest filing
- Aug 12, 2025
KALV holding history
KalVista Pharmaceuticals, Inc. in every 13F filed by Martin Worley Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
KALV overviewAll 13F holders of KALVFull Q2 2025 holdings
- Shares (Q2 2025)
- 10,168
- Value
- $114.9K
- % of portfolio
- 0.1%
- Quarters held
- 3
- Since Q4 2024